A prospective, multinational observational survey, ECAS evaluated the prevalence, incidence, and treatment of anaemia in 15 European cancer patients, of whom had gynaecologic malignancies Ludwig et al, Analysis ENMIC 4BBX plus the survey data showed that the prevalence and incidence of anaemia in the gynaecologic subgroup were From this it can be inferred that a substantial proportion of anemic gynaecologic cancer patients experience ENMIC 4BBX plus decline in functional capacity, with a subsequent decline in QOL. Given the many negative[…]
